Long-Term Outcomes After the Percutaneous Treatment of Drug-Eluting Stent Restenosis
Authors:
- Azeem LatibAzeem Latib
- Marco MussardoMMMarco Mussardo
- Alfonso IelasiAIAlfonso Ielasi
- Giandomenico TarsiaGTGiandomenico Tarsia
- Cosmo GodinoCGCosmo Godino
- Rasha Al-LameeRARasha Al-Lamee
- Alaide ChieffoACAlaide Chieffo
- Flavio AiroldiFAFlavio Airoldi
- Mauro CarlinoMCMauro Carlino
- Matteo MontorfanoMMMatteo Montorfano
- Antonio ColomboACAntonio Colombo
- 1 February 2011
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 4 (2) , 155-164
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting StentsJACC, 2010
- Tratamiento de la reestenosis de stents liberadores de paclitaxel mediante implantación de stents liberadores de sirolimus. Resultados angiográficos y clínicosRevista Espanola de Cardiologia, 2008
- Tratamiento de la reestenosis de un stent liberador de fármacos con otro stent liberador de fármacos: ¡no fallar en el segundo intento!Revista Espanola de Cardiologia, 2008
- Universal Definition of Myocardial InfarctionJACC, 2007
- Comparable Clinical Outcomes With Paclitaxel- and Sirolimus-Eluting Stents in Unrestricted Contemporary PracticeJACC, 2007
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stentAmerican Heart Journal, 2007
- ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary ArticleJACC, 2006
- Angiographic Patterns of In-Stent RestenosisCirculation, 1999
- Interlesion Dependence of the Risk for Restenosis in Patients With Coronary Stent Placement in Multiple LesionsCirculation, 1998